Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruna Gigante

Showing results (11-20 of 170) with videos related to

Pageof 17
Sort By:
BMC Geriatrics|December 9, 2025
Hospitalizations for cardiovascular events and risk for all cause and cardiovascular mortality in elderly patients with atrial fibrillation treated with oral anticoagulants: beyond preventing thromboembolismMatteo Candeloro, Qiaosen Chen, Hanne Ehrlinder, et al.
Cellular and Molecular Neurobiology|October 16, 2004
Role of genetic factors in the etiopathogenesis of cerebrovascular accidents: from an animal model to the human diseaseSperanza Rubattu, Rosita Stanzione, Bruna Gigante, et al.
Heart (British Cardiac Society)|March 4, 2016
Chocolate consumption and risk of myocardial infarction: a prospective study and meta-analysisSusanna C Larsson, Agneta Åkesson, Bruna Gigante, et al.
Annals of Medicine|November 12, 2015
Pulse pressure is not an independent predictor of incident atrial fibrillation in 60-year-old men and womenCharlotte Miedel, Karin Leander, Ulf de Faire, et al.
Research and Practice in Thrombosis and Haemostasis|October 31, 2022
Antithrombotic treatment switching in elderly patients with atrial fibrillation and the risk of thromboembolism, bleeding, and cardiac deathHanne Ehrlinder, Nicola Orsini, Karin Modig, et al.
Cytokine|September 3, 2022
IL-6 signalling biomarkers in hospitalised patients with moderate to severe SARS-CoV-2 infection in a single centre study in SwedenLouise Ziegler, Annika Lundström, Sebastian Havervall, et al.
Open Heart|October 12, 2021
Interleukin 6 trans-signalling and the risk of future cardiovascular events in men and womenYasmin Miri, Karin Leander, Per Eriksson, et al.
BMC Cardiovascular Disorders|October 17, 2012
Chromosome 1p13 genetic variants antagonize the risk of myocardial infarction associated with high ApoB serum levelsBruna Gigante, Karin Leander, Max Vikström, et al.
BMC Neurology|August 10, 2021
IL6 trans-signaling associates with ischemic stroke but not with atrial fibrillationLouise Ziegler, Håkan Wallén, Sara Aspberg, et al.
European Journal of Preventive Cardiology|August 24, 2019
The predictive role of interleukin 6 trans-signalling in middle-aged men and women at low-intermediate risk of cardiovascular eventsLouise Ziegler, Paolo Frumento, Håkan Wallén, et al.
Pageof 17

Showing results (11-20 of 170) with videos related to

Sort By:
Pageof 17
BMC Geriatrics|December 9, 2025
Hospitalizations for cardiovascular events and risk for all cause and cardiovascular mortality in elderly patients with atrial fibrillation treated with oral anticoagulants: beyond preventing thromboembolismMatteo Candeloro, Qiaosen Chen, Hanne Ehrlinder, et al.
Cellular and Molecular Neurobiology|October 16, 2004
Role of genetic factors in the etiopathogenesis of cerebrovascular accidents: from an animal model to the human diseaseSperanza Rubattu, Rosita Stanzione, Bruna Gigante, et al.
Heart (British Cardiac Society)|March 4, 2016
Chocolate consumption and risk of myocardial infarction: a prospective study and meta-analysisSusanna C Larsson, Agneta Åkesson, Bruna Gigante, et al.
Annals of Medicine|November 12, 2015
Pulse pressure is not an independent predictor of incident atrial fibrillation in 60-year-old men and womenCharlotte Miedel, Karin Leander, Ulf de Faire, et al.
Research and Practice in Thrombosis and Haemostasis|October 31, 2022
Antithrombotic treatment switching in elderly patients with atrial fibrillation and the risk of thromboembolism, bleeding, and cardiac deathHanne Ehrlinder, Nicola Orsini, Karin Modig, et al.
Cytokine|September 3, 2022
IL-6 signalling biomarkers in hospitalised patients with moderate to severe SARS-CoV-2 infection in a single centre study in SwedenLouise Ziegler, Annika Lundström, Sebastian Havervall, et al.
Open Heart|October 12, 2021
Interleukin 6 trans-signalling and the risk of future cardiovascular events in men and womenYasmin Miri, Karin Leander, Per Eriksson, et al.
BMC Cardiovascular Disorders|October 17, 2012
Chromosome 1p13 genetic variants antagonize the risk of myocardial infarction associated with high ApoB serum levelsBruna Gigante, Karin Leander, Max Vikström, et al.
BMC Neurology|August 10, 2021
IL6 trans-signaling associates with ischemic stroke but not with atrial fibrillationLouise Ziegler, Håkan Wallén, Sara Aspberg, et al.
European Journal of Preventive Cardiology|August 24, 2019
The predictive role of interleukin 6 trans-signalling in middle-aged men and women at low-intermediate risk of cardiovascular eventsLouise Ziegler, Paolo Frumento, Håkan Wallén, et al.
Pageof 17